Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense

Anticancer oncolytic activity of respiratory syncytial virus

(2009) I Echchgadda et al.   CANCER GENE THERAPY

Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer

(2009) Qianben Wang et al.   CELL

Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways

(2009) Shruthi Naik et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Genomic Strategy for Targeting Therapy in Castration-Resistant Prostate Cancer

(2009) Prateek Mendiratta et al.   JOURNAL OF CLINICAL ONCOLOGY

Activation of innate immune antiviral responses by Nod2

(2009) Ahmed Sabbah et al.   NATURE IMMUNOLOGY

Perfluorononanoic acid-induced apoptosis in rat spleen involves oxidative stress and the activation of caspase-independent death pathway

(2009) Xuemei Fang et al.   TOXICOLOGY

Role of Human β-Defensin-2 during Tumor Necrosis Factor-α/NF-κB-mediated Innate Antiviral Response against Human Respiratory Syncytial Virus

(2008) Srikanth Kota et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Early Steps of the Virus Replication Cycle Are Inhibited in Prostate Cancer Cells Resistant to Oncolytic Vesicular Stomatitis Virus

(2008) B. L. Carey et al.   JOURNAL OF VIROLOGY

Catabolic mediators of cancer cachexia

(2008) Michael J Tisdale   Current Opinion in Supportive and Palliative Care

Induction of type I interferons and interferon-inducible Mx genes during respiratory syncytial virus infection and reinfection in cotton rats

(2007) L. M. Pletneva et al.   JOURNAL OF GENERAL VIROLOGY